Onconetix Major Shareholder Increases Stake with 92,554 Share Purchase

Financial Lp Hrt boosts ownership in the biotech company by nearly 90%

Apr. 16, 2026 at 7:20pm

Got story updates? Submit your updates here. ›

An extreme close-up of intricate, metallic financial machinery and equipment, such as circuit boards and computer servers, rendered in a high-contrast, industrial style that conceptually represents the complex workings of the biotech industry.A major shareholder's substantial increase in Onconetix stock ownership signals confidence in the biotech company's financial infrastructure and growth potential.Cincinnati Today

Onconetix, Inc. (NASDAQ:ONCO) major shareholder Financial Lp Hrt acquired 92,554 shares of the biotech company's stock in a transaction on April 15th. The shares were purchased at an average cost of $0.76 per share, for a total transaction of $70,341.04. This trade represents an 88.57% increase in Financial Lp Hrt's ownership stake in Onconetix.

Why it matters

The significant increase in ownership by a major shareholder could signal confidence in Onconetix's future prospects and growth potential. As a biotech company focused on men's health and oncology solutions, Onconetix's performance is closely watched by investors.

The details

Following the transaction, Financial Lp Hrt now directly owns 197,052 shares in Onconetix, valued at $149,759.52. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.

  • The share purchase transaction occurred on Wednesday, April 15th, 2026.

The players

Financial Lp Hrt

A major shareholder of Onconetix, Inc. that has increased its ownership stake in the company by nearly 90% through this recent share purchase.

Onconetix, Inc.

A biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology, including FDA-approved products Entadfi and Proclarix.

Got photos? Submit your photos here. ›

The takeaway

This significant increase in ownership by a major shareholder suggests Financial Lp Hrt sees strong growth potential in Onconetix's pipeline of men's health and oncology solutions. As a biotech company, Onconetix's performance will continue to be closely monitored by investors.